Cytoreductive Surgery & Peritoneum ·
Mucinous and non-mucinous appendiceal adenocarcinomas exhibit differences in recurrence rates and nodal positivity. Colectomy is associated with improved disease-specific survival for non-mucinous tumors at certain stages and grades, but not for mucinous tumors. This suggests that colectomy may not be necessary for mucinous appendiceal adenocarcinoma patients.
Journal Article by Tsagkalidis V, Choe JK (…) Ecker BL et 9 al. in Ann Surg Oncol
© 2024. The Author(s).
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in Cytoreductive Surgery & Peritoneum
In patients with gastric cancer and positive peritoneal lavage cytology or localized peritoneal metastasis, upfront chemotherapy followed by surgery yields better outcomes than surgery followed by chemotherapy.
Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.
Secondary cytoreductive surgery with hyperthermic intraperitoneal chemotherapy improves survival for select patients with recurrent colorectal cancer peritoneal metastases.
